Molecular Epidemiology of Carbapenem Resistant Klebsiella Pneumoniae in Northern China: Clinical Characteristics, Antimicrobial Resistance, Virulence and Geographic Distribution

References

• Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016;80(3):629–661. doi:10.1128/MMBR.00078-15
   PubMed Web of Science ®Google Scholar
• Nagaraj G, Shamanna V, Govindan V, et al. High-resolution genomic profiling of carbapenem-resistant Klebsiella pneumoniae isolates: a multicentric retrospective Indian study. Clin Infect Dis. 2021;73(Suppl_4):S300–S307. doi:10.1093/cid/ciab767
   PubMedGoogle Scholar
• Holt KE, Wertheim H, Zadoks RN, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A. 2015;112(27):E3574–E3581. doi:10.1073/pnas.1501049112
   PubMed Web of Science ®Google Scholar
• Agyeman AA, Bergen PJ, Rao GG, Nation RL, Landersdorfer CB. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections. Int J Antimicrob Agents. 2020;55(1):105833. doi:10.1016/j.ijantimicag.2019.10.014
   PubMed Web of Science ®Google Scholar
• CARSS. China antimicrobial resistance surveillance system; 2022. Available from: http://carss.cn/. Accessed February 20, 2022.
   Google Scholar
• CHINET China antimicrobial surveillance network; 2022. Available from: http://www.chinets.com/Chinet/Index. Accessed February 20, 2022.
   Google Scholar
• Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20(3):440–458. doi:10.1128/CMR.00001-07
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu C, Shen Z, et al. Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008–2018. Emerg Microbes Infect. 2020;9(1):1771–1779. doi:10.1080/22221751.2020.1799721
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE Study in China (2012–2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205. doi:10.1093/cid/ciy660
   PubMed Web of Science ®Google Scholar
• Yang X, Sun Q, Li J, et al. Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae in China. Emerg Microbes Infect. 2022;11(1):841–849. doi:10.1080/22221751.2022.2049458
   PubMed Web of Science ®Google Scholar
• Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18(1):37–46. doi:10.1016/S1473-3099(17)30489-9
   PubMed Web of Science ®Google Scholar
• Du P, Zhang Y, Chen C. Emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Lancet Infect Dis. 2018;18(1):23–24. doi:10.1016/S1473-3099(17)30625-4
   PubMed Web of Science ®Google Scholar
• CaLS I. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: Clinical and Laboratory Standards Institute; 2021.
   Google Scholar
• Saki M, Amin M, Savari M, Hashemzadeh M, Seyedian SS. Beta-lactamase determinants and molecular typing of carbapenem-resistant classic and hypervirulent Klebsiella pneumoniae clinical isolates from southwest of Iran. Front Microbiol. 2022;2:13.
   Google Scholar
• Wang X, Li Q, Kang J, et al. Co-Production of NDM-1, CTX-M-9 Family and mcr-1 in a Klebsiella pneumoniae ST4564 Strain in China. Infect Drug Resist. 2021;14:449–457. doi:10.2147/IDR.S292820
   PubMed Web of Science ®Google Scholar
• Liu Y, Bai J, Kang J, et al. Three novel sequence types carbapenem-resistant Klebsiella pneumoniae strains ST5365, ST5587, ST5647 Isolated from two tertiary teaching general hospitals in Shanxi Province, in North China: molecular characteristics, resistance and virulence factors. Infect Drug Resist. 2022;15:2551–2563. doi:10.2147/IDR.S366480
   PubMed Web of Science ®Google Scholar
• Wu C, Zheng L, Yao J. Analysis of risk factors and mortality of patients with carbapenem-resistant Klebsiella pneumoniae infection. Infect Drug Resist. 2022;15:2383–2391. doi:10.2147/IDR.S362723
   PubMed Web of Science ®Google Scholar
• Chen J, Ma H, Huang X, et al. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study. Antimicrob Resist Infect Control. 2022;11(1):161. doi:10.1186/s13756-022-01204-w
   PubMed Web of Science ®Google Scholar
• Yan Z, Zhou Y, Du M, et al. Prospective investigation of carbapenem-resistant Klebsiella pneumonia transmission among the staff, environment and patients in five major intensive care units, Beijing. J Hosp Infect. 2019;101(2):150–157. doi:10.1016/j.jhin.2018.11.019
   PubMed Web of Science ®Google Scholar
• Pouch SM, Kubin CJ, Satlin MJ, et al. Epidemiology and outcomes of carbapenem‐resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients. Trans Infect Dis. 2015;17(6):800–809. doi:10.1111/tid.12450
   PubMed Web of Science ®Google Scholar
• Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. doi:10.1186/s12941-017-0191-3
   PubMed Web of Science ®Google Scholar
• Simkins J, Muggia V, Cohen HW, Minamoto GY. Carbapenem‐resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case–control study. Trans Infect Dis. 2014;16(5):775–782. doi:10.1111/tid.12276
   PubMed Web of Science ®Google Scholar
• Hoxha A, Kärki T, Giambi C, et al. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012–2013. J Hos Infect. 2016;92(1):61–66. doi:10.1016/j.jhin.2015.06.018
   PubMed Web of Science ®Google Scholar
• Zhang H, Guo Z, Chai Y, et al. Risk factors for and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae nosocomial infections: a retrospective study in a tertiary hospital in Beijing, China. Infect Drug Resist. 2021;14:1393–1401. doi:10.2147/IDR.S298530
   PubMed Web of Science ®Google Scholar
• Zhang R, Liu L, Zhou H, et al. Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China. EBioMedicine. 2017;19:98–106. doi:10.1016/j.ebiom.2017.04.032
   PubMed Web of Science ®Google Scholar
• David S, Reuter S, Harris SR, et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Microbiol. 2019;4(11):1919–1929. doi:10.1038/s41564-019-0492-8
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang S, Fang R, et al. Dynamic epidemiology and virulence characteristics of carbapenem-resistant Klebsiella pneumoniae in Wenzhou, China from 2003 to 2016. Infect Drug Resist. 2020;13:931–940. doi:10.2147/IDR.S243032
   PubMed Web of Science ®Google Scholar
• Saavedra SY, Bernal JF, Montilla-Escudero E, et al. Complexity of genomic epidemiology of carbapenem-resistant Klebsiella pneumoniae isolates in Colombia urges the reinforcement of whole genome sequencing-based surveillance programs. Clin Infect Dis. 2021;73(Suppl_4):S290–S299. doi:10.1093/cid/ciab777
   PubMedGoogle Scholar
• Liu Z, Gu Y, Li X, et al. Identification and characterization of NDM-1-producing hypervirulent (Hypermucoviscous) Klebsiella pneumoniae in China. Ann Lab Med. 2019;39(2):167–175. doi:10.3343/alm.2019.39.2.167
   PubMed Web of Science ®Google Scholar
• Gondal AJ, Saleem S, Jahan S, Choudhry N, Yasmin N. Novel carbapenem-resistant Klebsiella pneumoniae ST147 coharboring bla (NDM-1), bla (OXA-48) and extended-spectrum beta-lactamases from Pakistan. Infect Drug Resist. 2020;13:2105–2115. doi:10.2147/IDR.S251532
   PubMed Web of Science ®Google Scholar
• Evans BA, Amyes SG. OXA beta-lactamases. Clin Microbiol Rev. 2014;27(2):241–263. doi:10.1128/CMR.00117-13
   PubMed Web of Science ®Google Scholar
• Zhang F, Wang X, Xie L, et al. A novel transposon, Tn6306, mediates the spread of bla(IMI) in Enterobacteriaceae in hospitals. Int J Infect Dis. 2017;65:22–26. doi:10.1016/j.ijid.2017.09.014
   PubMed Web of Science ®Google Scholar
• Dabos L, Patino-Navarrete R, Nastro M, et al. SME-4-producing Serratia marcescens from Argentina belonging to clade 2 of the S. marcescens phylogeny. J Antimicrob Chemother. 2019;74(7):1836–1841. doi:10.1093/jac/dkz115
   PubMed Web of Science ®Google Scholar
• Bai J, Liu Y, Kang J, et al. Antibiotic resistance and virulence characteristics of four carbapenem-resistant Klebsiella pneumoniae strains coharbouring bla(KPC) and bla(NDM) based on whole genome sequences from a tertiary general teaching hospital in central China between 2019 and 2021. Microb Pathog. 2023;175:105969. doi:10.1016/j.micpath.2023.105969
   PubMed Web of Science ®Google Scholar
• Gao H, Liu Y, Wang R, Wang Q, Jin L, Wang H. The transferability and evolution of NDM-1 and KPC-2 co-producing Klebsiella pneumoniae from clinical settings. EBioMedicine. 2020;51:102599. doi:10.1016/j.ebiom.2019.102599
   PubMed Web of Science ®Google Scholar
• Wang M, Earley M, Chen L, et al. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. Lancet Infect Dis. 2022;22(3):401–412. doi:10.1016/S1473-3099(21)00399-6
   PubMed Web of Science ®Google Scholar
• Kazemian H, Heidari H, Ghanavati R, et al. Phenotypic and genotypic characterization of ESBL-, AmpC-, and carbapenemase-producing Klebsiella pneumoniae and Escherichia coli Isolates. Med Princ Pract. 2019;28(6):547–551. doi:10.1159/000500311
   PubMed Web of Science ®Google Scholar
• Zhao L, Xia X, Yuan T, Zhu J, Shen Z, Li M. Molecular epidemiology of antimicrobial resistance, virulence and capsular serotypes of carbapenemase-carrying Klebsiella pneumoniae in China. Antibiotics. 2022;11:8.
   Google Scholar
• Li Q, Zhu J, Kang J, et al. Emergence of NDM-5-producing carbapenem-resistant Klebsiella pneumoniae and SIM-producing hypervirulent Klebsiella pneumoniae isolated from aseptic body fluid in a large tertiary hospital, 2017–2018: genetic traits of blaNDM-like and blaSIM-like genes as determined by NGS. Infect Drug Resist. 2020;13:3075–3089. doi:10.2147/IDR.S261117
   PubMedGoogle Scholar
• Zhou K, Xiao T, David S, et al. Novel subclone of carbapenem-resistant Klebsiella pneumoniae sequence type 11 with enhanced virulence and transmissibility, China. Emerg Infect Dis. 2020;26(2):289–297. doi:10.3201/eid2602.190594
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang T, Chen L, Du H. Virulence factors in hypervirulent Klebsiella pneumoniae. Front Microbiol. 2021;12:642484. doi:10.3389/fmicb.2021.642484
   PubMed Web of Science ®Google Scholar
• Wang L, Shen D, Wu H, Ma Y. Resistance of hypervirulent Klebsiella pneumoniae to both intracellular and extracellular killing of neutrophils. PLoS One. 2017;12:3.
   Web of Science ®Google Scholar
• Lee CH, Chuah SK, Chang CC, Chen FJ. The surface protein fructose-1, 6 bisphosphate aldolase of Klebsiella pneumoniae Serotype K1: role of interaction with neutrophils. Pathogens. 2020;9(12):1009. doi:10.3390/pathogens9121009
   PubMed Web of Science ®Google Scholar
• Karah N, Sundsfjord A, Towner K, Samuelsen O. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat. 2012;15(4):237–247. doi:10.1016/j.drup.2012.06.001
   PubMed Web of Science ®Google Scholar